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Background: Postoperative ileus and anastomotic leakage are important complications following colorectal surgery
associated with short-term morbidity and mortality. Previous experimental and preclinical studies have shown that a
short intervention with enriched enteral nutrition dampens inflammation via stimulation of the autonomic nervous
system and thereby reduces postoperative ileus. Furthermore, early administration of enteral nutrition reduced
anastomotic leakage. This study will investigate the effect of nutritional stimulation of the autonomic nervous system
just before, during and early after colorectal surgery on inflammation, postoperative ileus and anastomotic leakage.
Methods/Design: This multicenter, prospective, double-blind, randomized controlled trial will include 280 patients
undergoing colorectal surgery. All patients will receive a selfmigrating nasojejunal tube that will be connected to a
specially designed blinded tubing system. Patients will be allocated either to the intervention group, receiving
perioperative nutrition, or to the control group, receiving no nutrition. The primary endpoint is postoperative
ileus. Secondary endpoints include anastomotic leakage, local and systemic inflammation, (aspiration) pneumonia,
surgical complications classified according to Clavien-Dindo, quality of life, gut barrier integrity and time until functional
recovery. Furthermore, a cost-effectiveness analysis will be performed.
Discussion: Activation of the autonomic nervous system via perioperative enteral feeding is expected to dampen the
local and systemic inflammatory response. Consequently, postoperative ileus will be reduced as well as anastomotic
leakage. The present study is the first to investigate the effects of enriched nutrition given shortly before, during and
after surgery in a clinical setting.
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Postoperative ileus (POI) is considered to be an inevitable
consequence of colorectal surgery by many clinicians and
is associated with an increased morbidity and prolonged
hospital stay. Therapeutic strategies to cure this condition
of decreased gastrointestinal motility in our current health
system are lacking and at this moment only supportive
care is given to optimize the patient’s condition. Although
perioperative care is improved by several measures, such
as encouraging early mobilization, minimally invasive
surgery and standard anesthetic protocols as part of the
Enhanced Recovery After Surgery (ERAS) guidelines,
POI cannot be completely avoided and the incidence
remains substantial [1,2]. POI is caused by a local and
systemic inflammatory response associated with bowel
manipulation [3,4]. In experimental studies, it is shown
that nutritional stimulation of the autonomic nervous
system reduces the inflammatory response and POI via
a specific mechanism [5-7]. Ingestion of dietary lipids,
proteins and peptides triggers release of cholecysto-
kinin (CCK) via chylomicron formation [8]. CCK binds
to CCK-1 receptors located on vagal afferents, thereby
rapidly activating the autonomic nervous system and
subsequently activating efferent vagal nerve fibers lead-
ing to the release of acetylcholine. Acetylcholine then
binds to alpha-7-nicotinic receptors, located on inflam-
matory cells such as mast cells, triggering an intracellular
pathway that results in a decreased release of inflamma-
tory mediators [9-11]. Via this mechanism, POI can be
inhibited [9,10].
Also, in previous preclinical and clinical studies, our
group has shown that enteral nutrition and sham-feeding
via chewing gum are very effective means in the reduction
of POI and inflammation. When enteral nutrition was
started very early after colorectal surgery, POI was re-
duced from 35% to 16%. In a second study, using chewing
gum as a means to stimulate the autonomic nervous sys-
tem, a reduction of POI was seen from 48% in the control
group to 27% in the intervention group [12,13]. These
studies also revealed an as yet unaccountable effect on
anastomotic leakage (AL), resulting in an average reduc-
tion of 73%. AL is a dreaded complication following colo-
rectal surgery, which is associated with significant
morbidity and even mortality. It is a risk factor for local
recurrence of colorectal cancer and has a significant im-
pact on overall survival and quality of life [14].
Composition of the enteral nutrition and timing of ad-
ministration are essential for the magnitude of this re-
sponse. Administration of an enriched enteral formula
that optimally stimulates release of CCK via chylomicrons
just before, during and directly after the inciting event for
inflammation is pivotal [9]. The current study will investi-
gate whether enriched enteral nutrition given shortly be-
fore, during and early after colorectal surgery reduces POIand AL via stimulation of the autonomic nervous system
in a clinical setting. Given limited healthcare resources
and the increasing importance of economic evaluation, we
also plan to estimate the cost-effectiveness of this inter-
vention in the current medical healthcare system.
Study objectives
The objective is to investigate whether enriched enteral
nutrition given shortly before, during and early after colo-
rectal surgery, reduces POI and AL via stimulation of the
autonomic nervous system in a clinical setting, compared
with standard care. The primary outcome will be POI.
Secondary outcomes will include effects of perioperative
nutrition compared with standard of care on AL, aspir-
ation pneumonia, gastric volumes preoperatively, time
until functional recovery, inflammatory markers, intes-
tinal barrier integrity, surgical complications according
to Clavien-Dindo and health-related quality of life. Fur-
thermore, a cost-effectiveness analysis and a cost-utility
analysis will be performed.
Methods/Design
This is a multicenter, prospective, double-blind, randomized
controlled superiority trial with two parallel groups. A writ-
ten informed consent needs to be obtained from every pa-
tient. The trial will be conducted according to the rules of
Good Clinical Practice, and a Data Safety Monitoring Board
(DSMB) is installed to monitor (serious) adverse events.
Ethical approval for this study was granted by the Medical
Ethics Committee Catharina Hospital (Eindhoven, The
Netherlands) under reference number NL45640.060.13.
Study population
Patients aged >18 undergoing elective segmental colorec-
tal resection with an anastomosis are eligible for inclusion.
A total of 280 patients will be included. Exclusion criteria
are previous gastric or esophageal resection, peritoneal
carcinomatosis, pre-existent or creation of an ileostomy,
steroid use and use of medication that disrupts the acetyl-
choline metabolism, such as selective serotonin reuptake
inhibitors and anticonvulsants. Both the investigator and
the responsible surgeon will verify eligibility. If the indica-
tion for operation is established, the patient will receive
written and oral information about the trial during a
scheduled outpatient appointment. Patients will be offered
sufficient time to enquire about details of the trial and to
decide whether or not they wish to participate. Patients
will have to sign the informed consent form in the phys-
ical presence of the surgeon or investigator. A participant
flow diagram is shown in Figure 1.
Participating centers
Patients eligible for this study will be initially included in
the Catharina Hospital, Eindhoven, The Netherlands.
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formed to assess feasibility and safety of perioperative nu-
trition. After this first safety analysis, this study will be
conducted in a multicenter setting. Also, when 140 pa-
tients are included, an interim-analysis will be performed.
The estimated duration of the recruitment period is
2 years.
Randomization
Patients will be randomized as block randomization with
a 1:1 allocation by means of randomization software
(TENALEA Clinical Trial Data Management System,
Amsterdam, The Netherlands). A selfmigrating nasojeju-
nal tube (Bengmark, Nutricia Flocare, Zoetermeer, The
Netherlands) will be inserted in all included patients. To
minimize aspiration, the nasojejunal tube needs to be
positioned postpylorically, which will be confirmed by
an abdominal X-ray. The patient will be randomized
after confirmation of a correct position of the nasojeju-
nal tube. Blinded stratification will be applied to ensure
an equal distribution between colonic or rectal surgery
and between a laparoscopic or an open procedure.
After randomization, enriched enteral nutrition (Nutri-
cia Research, Utrecht, The Netherlands) will be started via
an electronic feeding pump (Infinity, Nutricia Flocare,
Zoetermeer, The Netherlands) in all patients. The nutri-
tion and the pump will be connected to a specially de-
signed opaque tubing system (ECMbv, Gemert, The
Netherlands) that is similar to what is used in daily prac-
tice. However, the tubing has a bifurcation with two
branches; one branch leads to the nasojejunal feeding tube
in the patient and one branch leads to a sealed container
(attached to the bed in all patients). For patients who willFigure 1 Flow diagram for participants who will be included in the studbe allocated to the intervention group, the tubing system
is open towards the patient and occluded towards the
container. For patients in the control group, the tubing
system is occluded towards the patient and open towards
the container. In this way, the patients in the intervention
group will receive enriched enteral nutrition, while the
patients in the control group will not. The tubing will
be labeled with a randomization number provided by
TENALEA. Independent research nurses will provide
the labeling of the tubing and store the allocation list.
The tubing system can easily be connected to all ma-
terials, including the standard enteral feeding system,
the nasojejunal feeding tube, and the container. The
containers will be sealed and weighted to prevent dif-
ferentiation between the groups by examining the con-
tainers. Neither the patient, nor the nursing staff or the
researchers will be able to see which branch of the tub-
ing system is occluded.
Study outline
The day before surgery, all patients will receive a selfmi-
grating nasojejunal feeding tube at the ward. The position
of the nasojejunal tube will be verified by means of ab-
dominal X-ray. Preoperatively, all patients will be fasted
for oral solid foods for a period of 6 hours, and oral liquids
for a period of 2 hours. Three hours before surgery, the
pump with enriched tube feeding will be started at a con-
tinuous rate of 1.5 ml/minute in all patients. Subsequently,
6 hours after surgery, the feeding pump will be stopped
and the nasojejunal tube will be removed. Depending on
the randomization outcome, the nutrition will be adminis-
tered either to the patient, or into the sealed container.
This setup allows a double-blind comparison between they. *Blinded groups and blinded outcome. NJ tube = nasojejunal tube.
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enriched enteral nutrition. The fixed timeframe and the
administration of feeding by electronic pump will support
adherence to the study protocol. Anesthetic regimens will
be standardized and registered per patient, as will the
standardized postoperative care. Participants should con-
tinue to take medication for other conditions as usual.
Both the rate of infusion and the composition of the nu-
trition have been described in previous studies [9]. Fur-
thermore, the nutrition has been tested in healthy
volunteers and is well tolerated [9]. The enriched nutrition
contains 44 energy percent (en%) fat, 25 en% protein, and
31 en% carbohydrates. The protein fraction consists of in-
tact casein, whey protein, and soy protein hydrolysate.
The lipid fraction contains less than 5 weight percent
omega-3 fatty acids.
Perioperative nutrition is a new concept with a poten-
tial risk of aspiration pneumonia. In this trial, nutrition
will be administered postpylorically, thereby reducing
gastric volumes. To minimize risk of aspiration pneumo-
nia the stomach will be emptied by means of a gastric
tube before surgery. Gastric volumes will be measured
in every patient when the stomach is emptied before sur-
gery in the operating room. By giving the nutrition post-
pylorically, in a low volume and assuring an empty
stomach before intubation, the risk of complications will
be minimized.
A Data Safety Monitoring Board (DSMB) has been in-
stalled to evaluate all complications and monitor patient
safety. If a serious event regarding safety of preoperative
feeding (for example, aspiration pneumonia) occurs, the
DSMB will be informed, who will then discuss the con-
sequences and report their advice to the investigator and
Medical Ethics Committee.
POI is defined in accordance with a standardized defin-
ition, and will be measured clinically. POI is established if
both of the following criteria are met: lack of passage of
flatus or stool, and inability to tolerate an oral diet in the
interval between surgery and postoperative day 4 [15].
Prolonged POI is established if 2 or more of the follow-
ing criteria are met on or after postoperative day 4 without
prior resolution of POI: nausea or vomiting, inability to
tolerate an oral diet over the last 24 hours, absence of fla-
tus over the last 24 hours, abdominal distension, and/or
radiologic confirmation.
In addition, gastric motility will be measured by means
of ultrasound of the gastric antrum before and after a
standardized meal on the second postoperative day. Pre-
vious studies have shown that ultrasonic gastric antrum
measurements are representative for determining gastric
emptying and gastric motility by determining the change
in the gastric antral cross sectional area of the stomach
before a standardized meal, and 15 and 90 minutes post-
prandially [16].AL is defined as clinical and radiological signs of anas-
tomotic leakage, if confirmed by re-operation or if an
enterocutaneous fistula occurs. Blood plasma, peritoneal
lavage fluid and tissue samples will be collected at prede-
fined time-points before, during and after surgery. All
samples will be stored at −80°C until further analysis.
These samples will be analyzed for markers of the in-
flammatory response and gut barrier integrity using im-
munohistochemistry, Western blot, ELISA and/or PCR.
Patient characteristics, nutritional status and clinical pa-
rameters will be registered prospectively. Surgical com-
plications will be classified using the Clavien-Dindo
classification [17]. Quality of life will be measured pre-
operatively and postoperatively at 3 and 6 months after
surgery via checklists (EORTC QLQ C-30 in cancer pa-
tients and EuroQol-5D-5L (EQ-5D-5L)).
The total follow-up for this study is 6 months. All data
will be registered on a paper case report form and in an
electronic database. The principal investigator and the
local investigators will have access to the dataset.Statistical analysis
The sample size is calculated with a power analysis and is
aimed at POI and AL, based on previous studies of our
group [12,13]. For POI, these previous data show a mean
incidence of 40% and a reduction of almost 50% by nutri-
tion or sham-feeding. Based on a power of 0.8 and an
alpha of 0.05, a total of 91 patients are needed per group.
For AL, our previous data show a mean incidence of 13%
and a reduction to 3.5% by nutrition or sham-feeding.
Using a power of 0.8 and a drop-out percentage of 5%, a
total of 140 patients are needed per group. In this way
both the primary endpoint and the most important sec-
ondary endpoint AL will be adequately powered and a
multicomparison correction will not be applied in the final
analysis.
All analyses will be done according to the intention-to-
treat approach, which includes all randomized patients,
regardless of adherence to study protocol. Occurrences of
the primary and secondary endpoints will be compared
between the intervention group and the control group.
Results will be presented as risk ratios with corresponding
95% confidence intervals. A 2-tailed P-value < 0.05 is con-
sidered statistically significant. To compare the groups,
the data will be tested for normal distribution, and an un-
paired t-test will be performed if appropriate, otherwise
the Mann-Whitney U-test, Chi-square test or Fisher's
exact test will be used.Economic evaluation design
A cost-effectiveness analysis and a cost-utility analysis will
be performed to assess the economic value of periopera-
tive nutrition compared with usual care. The incremental
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cremental costs per point change in POI and AL, and the
incremental cost-utility ratio (ICUR) will be expressed
as the incremental costs per quality-adjusted life years
(QALYs) gained. Quality of life will be measured using
the EORTC QLQ C-30 and EQ-5D-5L questionnaires.
A societal perspective will be used for cost evaluation.
We will consider cost factors in three categories:
healthcare sector costs (direct costs such as personnel,
operation, or diagnostics), patient and family costs (out-
of-pocket expenses, travel expenses), and costs in other
sectors (mainly cost due to absenteeism in paid work and
production losses in the domestic sphere). Healthcare
costs, costs to patients and family, and costs occurring in
other sectors will be measured at the individual (partici-
pant) level using data from registration systems of the
hospitals and patient questionnaires (including adapted
version of the iMTA Medical Consumption Questionnaire
(iMCQ) and the iMTA Productivity Cost Questionnaire
(iPCQ)). Finally, monetary values will be assigned to the
relevant cost factors. The identified health services con-
sumed by study participants will be multiplied with their
corresponding unit prices. Total costs will be determined
by summing up the costs of individual services. The up-
dated Dutch manual for costing in economic evaluations
in healthcare will be used in the valuation step of health-
care costs and patient cost. Costs will be indexed for the
year 2014.
ICER (and ICUR) will be estimated as the difference in
costs between perioperative nutrition and standard care
divided by their differences in outcomes. To quantify the
uncertainty around the ICER, non-parametric bootstrap-
ping will be conducted in Excel (Microsoft, Redmond,
WA, USA) (1,000 simulations). The results of the boot-
strapping will be plotted in the cost-effectiveness plane,
where the horizontal axis reflects differences in effects
and the vertical axis differences in costs, and will be rep-
resented as a cost-effective acceptability curve showing
the probability that perioperative nutrition is cost-effective
for a range of willingness-to-pay values. Additional sensi-
tivity analyses will be done to test the robustness of the
results.
Discussion
Despite advances that are being made in surgical tech-
nique and improvement in postoperative care, POI and
AL remain very important clinical determinants of short-
term morbidity and mortality following colorectal surgery.
In previous studies it was shown that 35 to 45% and 7 to
13% of patients experience POI and AL after elective colo-
rectal surgery, respectively [12,13]. Both POI and AL have
proven to be significant predictors of increased hospital
length of stay and hospital costs [2,18,19]. Furthermore,
AL is a risk factor for local recurrence of colorectal cancerand has a significant impact on disease-free and overall
survival [14]. It is, therefore, believed that improving post-
operative outcome following colorectal surgery will also
improve long-term oncological outcomes regarding over-
all survival and tumor recurrence [20].
Although the mechanism underlying POI has been
studied extensively in animal experiments, targeted thera-
peutic strategies are currently lacking in a clinical setting
and only supportive measures are taken to optimize the
patient’s recovery [21]. For POI it is believed that forma-
tion of an inflammatory infiltrate in the muscular layers of
the intestine following bowel manipulation during surgery
leads to a decreased gastrointestinal motility [4]. In previ-
ous experimental and clinical studies our group has shown
that a short intervention with enriched enteral nutrition
given just before and directly after the inciting event,
dampens the inflammatory response and reduces POI by
stimulation of the autonomic nervous system through re-
lease of CCK. Evidence on the relation between POI and
AL is scarce, but has a great impact. Early inhibition of
the inflammatory response may play a role, since release
of proinflammatory cytokines such as TNF-α modulates
intestinal epithelial function and is an inhibitory factor in
the wound healing process of intestinal anastomoses [22].
Nutrition is usually given to provide nutrients, or to ad-
minister specific nutrients with a potential therapeutic ef-
fect (for example, probiotics, omega-3 fatty acids) [23].
However, in this study enteral nutrition is used to directly
alter the immune response following colorectal surgery
via a newly discovered neuro-immunological feedback
mechanism. This is a new concept and changes the way of
thinking about the usage of enteral nutrition in a clinical
setting.
To optimally stimulate the release of CCK and thereby
activating the autonomic nervous system, a specific nu-
tritional formula will be used that is enriched in lipids
and proteins. Furthermore, this nutrition is administered
during surgery, which has been found to be most effect-
ive in experimental studies. We are not aware of previ-
ous, current or proposed studies with similar innovative
approaches. To ensure patient safety this study is con-
ducted according to the rules of Good Clinical Practice
and a Data Safety Monitoring Board is installed.
Improvement of postoperative care and reduction of
POI and AL is a complex challenge that requires a multi-
disciplinary approach. This clinical study will be per-
formed based on the hypothesis that early modulation of
the immune response by enriched enteral nutrition will
reduce POI and also affect AL. A reduction of postopera-
tive morbidity by this nutritional intervention may con-
tribute to an enhanced efficiency, resulting in measurable
improvements of productivity, cost and quality.
In conclusion, this study will investigate whether nutri-
tion can be used to reduce POI and AL following
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means to stimulate the autonomic nervous system and to
modulate the immune response directly. Furthermore, the
timing is essential for the magnitude of effect. Reduction
of POI and AL following colorectal surgery would not
only optimize surgical care for this large patient group
and thereby reduce healthcare costs, but may also open
new therapeutic opportunities and changes the way of
thinking about the usage of enteral nutrition in a clinical
setting.
Trial status
Open for inclusion since August 2014.
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